Dr. Michael Harris, MD (he/him) is an Endocrinologist in Beverly hills, CA with over 15 years of experience. What is your opinion of Dr. Michael Harris, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Michael Harris, MD has received over $14,188 which includes payments from the following companies:
$6,622.78 from sanofi-aventis U.S. LLC
$3,322.79 from INSULET CORPORATION
$2,455.84 from Novo Nordisk Inc
$865.00 from GlaxoSmithKline, LLC.
$281.73 from Dexcom, Inc.
$178.71 from AstraZeneca Pharmaceuticals LP
$150.09 from AbbVie, Inc.
$44.79 from LILLY USA, LLC
$31.56 from Medtronic MiniMed, Inc.
$25.50 from Roche Diabetes Care, Inc.
$23.33 from Takeda Pharmaceuticals America, Inc.
$23.33 from Shire North American Group Inc
$21.82 from Novartis Pharmaceuticals Corporation
$21.66 from MannKind Corporation
$20.50 from Fidia Pharma USA Inc
$17.99 from Amgen Inc.
$17.57 from KVK-Tech, Inc.
$17.02 from Merck Sharp & Dohme Corporation
$13.32 from VIVUS, Inc.
$11.33 from Endo Pharmaceuticals Inc.
Payments received by Dr. Michael Harris, MD were from the following categories:
$5,611.29 Consulting Fee
$5,304.11 Food and Beverage
$1,660.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!